Anemia of hematologic malignancies: what are the treatment options?
about
BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study.Anemia, cancer, and aging.The impact of hemoglobin level and transfusion on the outcomes of chemotherapy in gastric cancer patients.Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study.Quality of life and supportive care in multiple myeloma.Hemoglobin level trajectories in the early treatment period are related with survival outcomes in patients with breast cancer.
P2860
Anemia of hematologic malignancies: what are the treatment options?
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anemia of hematologic malignancies: what are the treatment options?
@ast
Anemia of hematologic malignancies: what are the treatment options?
@en
Anemia of hematologic malignancies: what are the treatment options?
@nl
type
label
Anemia of hematologic malignancies: what are the treatment options?
@ast
Anemia of hematologic malignancies: what are the treatment options?
@en
Anemia of hematologic malignancies: what are the treatment options?
@nl
prefLabel
Anemia of hematologic malignancies: what are the treatment options?
@ast
Anemia of hematologic malignancies: what are the treatment options?
@en
Anemia of hematologic malignancies: what are the treatment options?
@nl
P356
P1433
P1476
Anemia of hematologic malignancies: what are the treatment options?
@en
P2093
Heinz Ludwig
P356
10.1053/SONC.2002.33533
P433
P577
2002-06-01T00:00:00Z